Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 7053451, 15 pages
http://dx.doi.org/10.1155/2016/7053451
Research Article

Long-Term Alteration of Reactive Oxygen Species Led to Multidrug Resistance in MCF-7 Cells

1Key Laboratory of Natural Medicine and Immune Engineering, Henan University, Kaifeng, China
2School of Pharmacy, Henan University, Kaifeng, China

Received 18 August 2016; Revised 25 October 2016; Accepted 6 November 2016

Academic Editor: Jacek Zielonka

Copyright © 2016 Juan Cen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. I. Brown and K. K. Griendling, “Nox proteins in signal transduction,” Free Radical Biology and Medicine, vol. 47, no. 9, pp. 1239–1253, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. A. Starkov, “The role of mitochondria in reactive oxygen species metabolism and signaling,” Annals of the New York Academy of Sciences, vol. 1147, no. 12, pp. 37–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. V. I. Lushchak, “Adaptive response to oxidative stress: bacteria, fungi, plants and animals,” Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, vol. 153, no. 2, pp. 175–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Ozben, “Oxidative stress and apoptosis: impact on cancer therapy,” Journal of Pharmaceutical Sciences, vol. 96, no. 9, pp. 2181–2196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Mittler, S. Vanderauwera, N. Suzuki et al., “ROS signaling: the new wave?” Trends in Plant Science, vol. 16, no. 6, pp. 300–309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Fu, M. Lin, Y. Muroya et al., “Free radical scavenging reactions and antioxidant activities of silybin: mechanistic aspects and pulse radiolytic studies,” Free Radical Research, vol. 43, no. 9, pp. 887–897, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Tsuruo, M. Naito, A. Tomida et al., “Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal,” Cancer Science, vol. 94, no. 1, pp. 15–21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Kohanski, M. A. DePristo, and J. J. Collins, “Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis,” Molecular Cell, vol. 37, no. 3, pp. 311–320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Gibellini, M. Pinti, M. Nasi et al., “Interfering with ROS metabolism in cancer cells: the potential role of quercetin,” Cancers, vol. 2, no. 2, pp. 1288–1311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Cook, D. Gius, D. A. Wink, M. C. Krishna, A. Russo, and J. B. Mitchell, “Oxidative stress, redox, and the tumor microenvironment,” Seminars in Radiation Oncology, vol. 14, no. 3, pp. 259–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. L. K. Eidus, M. O. Emel'ianov, A. F. Korystova, L. N. Kublik, V. V. Shaposhnikova, and I. N. Korystov, “Multidrug resistance increase of tumor cells at the effect of radiation and phorbol ether depends on protein kinase C and reactive oxygen species,” Radiatsionnaia Biologiia, Radioecologiia, vol. 50, no. 1, pp. 37–41, 2010. View at Google Scholar · View at Scopus
  12. J. Wang, L. Liu, J. Cen, and B. Ji, “BME, a novel compound of anthraquinone, down regulated P-glycoprotein expression in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells via generation of reactive oxygen species,” Chemico-Biological Interactions, vol. 239, no. 1, pp. 139–145, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. E. H. Walker, M. E. Pacold, O. Perisic et al., “Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine,” Molecular Cell, vol. 6, no. 4, pp. 909–919, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Zhu, Y. Feng, J. Zhang et al., “Inhibition of hypoxia inducible factor 1α expression suppresses the progression of esophageal squamous cell carcinoma,” Cancer Biology and Therapy, vol. 11, no. 11, pp. 981–987, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Skehan, R. Storeng, D. Scudiero et al., “New colorimetric cytotoxicity assay for anticancer-drug screening,” Journal of the National Cancer Institute, vol. 82, no. 13, pp. 1107–1112, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Zielonka, J. Vasquez-Vivar, and B. Kalyanaraman, “Detection of 2-hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine,” Nature Protocols, vol. 3, no. 1, pp. 8–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. D. C. Fernandes, J. Wosniak Jr., L. A. Pescatore et al., “Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems,” American Journal of Physiology—Cell Physiology, vol. 292, no. 1, pp. C413–C422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Cen, Y.-L. Zhu, Y. Yang et al., “Effects of the multidrug resistance modulator HZ08 on the apoptosis pathway in human chronic leukaemia cell line K562/A02,” Arzneimittel-Forschung, vol. 61, no. 11, pp. 622–630, 2011. View at Google Scholar · View at Scopus
  19. J. Cen, L. Liu, M.-S. Li et al., “Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats,” Journal of Pharmacy and Pharmacology, vol. 65, no. 5, pp. 665–672, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. O. G. Lyublinskaya, V. V. Zenin, A. N. Shatrova et al., “Intracellular oxidation of hydroethidine: compartmentalization and cytotoxicity of oxidation products,” Free Radical Biology and Medicine, vol. 75, no. 10, pp. 60–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Suttana, S. Mankhetkorn, W. Poompimon et al., “Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols,” Molecular Cancer, vol. 9, no. 1, article 99, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Cort, T. Ozben, L. Saso et al., “Redox control of multidrug resistance and its possible modulation by antioxidants,” Oxidative Medicine and Cellular Longevity, vol. 11, no. 1, pp. 1–17, 2016. View at Google Scholar
  23. K. M. Comerford, T. J. Wallace, J. Karhausen, N. A. Louis, M. C. Montalto, and S. P. Colgan, “Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene,” Cancer Research, vol. 62, no. 12, pp. 3387–3394, 2002. View at Google Scholar · View at Scopus
  24. J. Zhang, M. Lu, F. Zhou et al., “Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2,” Drug Metabolism and Disposition, vol. 40, no. 10, pp. 1900–1908, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-K. Lee, A. Shehzad, J.-C. Jung et al., “Protein kinase Cα protects against multidrug resistance in human colon cancer cells,” Molecules and Cells, vol. 34, no. 1, pp. 61–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. W. Kim, D. Asai, J. H. Kang, A. Kishimura, T. Mori, and Y. Katayama, “Reversal of efflux of an anticancer drug in human drug-resistant breast cancer cells by inhibition of protein kinase Calpha (PKCα) activity,” Tumor Biology, vol. 37, no. 2, pp. 1901–1908, 2016. View at Publisher · View at Google Scholar
  27. J. Cen, Y. Qi, Y.-F. Tao et al., “HZ08, a great regulator to reverse multidrug: resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM,” European Journal of Pharmacology, vol. 647, no. 1–3, pp. 21–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Yu, X. Cheng, Y. Du, L. Yang, and L. Huang, “Significance of MDR-related proteins in the postoperative individualized chemotherapy of gastric cancer,” Journal of Cancer Research and Therapeutics, vol. 11, no. 1, pp. 46–50, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Gañán-Gómez, Y. Wei, H. Yang, M. C. Boyano-Adánez, and G. García-Manero, “Oncogenic functions of the transcription factor Nrf2,” Free Radical Biology and Medicine, vol. 65, pp. 750–764, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. G. N. Masoud and W. Li, “HIF-1α pathway: role, regulation and intervention for cancer therapy,” Acta Pharmaceutica Sinica B, vol. 5, no. 5, pp. 378–389, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. E. K. J. Pauwels, P. Erba, G. Mariani, and C. M. F. Gomes, “Multidrug resistance in cancer: its mechanism and its modulation,” Drug News and Perspectives, vol. 20, no. 6, pp. 371–377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. X.-H. Wang, D.-Z. Jia, Y.-J. Liang et al., “Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway,” Cancer Letters, vol. 249, no. 2, pp. 256–270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Arancia, A. Calcabrini, M. Marra et al., “Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells,” Amino Acids, vol. 26, no. 3, pp. 273–282, 2004. View at Google Scholar · View at Scopus
  34. A. K. Maiti, “Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells,” Pharmacogenomics Journal, vol. 10, no. 2, pp. 94–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. P. de Souza Votto, V. P. Renon, J. S. Yunes et al., “Sensitivity to microcystins: a comparative study in human cell lines with and without multidrug resistance phenotype,” Cell Biology International, vol. 31, no. 11, pp. 1359–1366, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. S.-Y. Tsai, N.-K. Sun, H.-P. Lu, M.-L. Cheng, and C. C.-K. Chao, “Involvement of reactive oxygen species in multidrug resistance of a vincristine-selected lymphoblastoma,” Cancer Science, vol. 98, no. 8, pp. 1206–1214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Deng, Y.-C. Lin-Lee, F.-X. Claret, and M. T. Kuo, “2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-κB pathway,” Journal of Biological Chemistry, vol. 276, no. 1, pp. 413–420, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Hong, Y. Lu, Z.-N. Ji, and G.-Q. Liu, “Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells,” Journal of Neurochemistry, vol. 98, no. 5, pp. 1465–1473, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. M. O. Emel'yanov, Y. A. Kim, A. F. Korystova et al., “Rapid suppression of multidrug resistance of leukemic cells by oxidative stress,” Biologicheskie Membrany, vol. 27, no. 3, pp. 244–251, 2010. View at Google Scholar
  40. Y. Cai, J. Lu, Z. Miao, L. Lin, and J. Ding, “Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells,” Cancer Biology and Therapy, vol. 6, no. 11, pp. 1794–1799, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. N. Korystov, “Effects of reactive oxygen species on the multidrug resistance of tumor cells,” Biologicheskie Membrany, vol. 30, no. 3, pp. 163–169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Li, J. Xu, T. Min, and W. Huang, “Up-regulation of P-glycoprotein expression by catalase via JNK activation in HepG2 cells,” Redox Report, vol. 11, no. 4, pp. 173–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. Y.-W. Liu, T. Sakaeda, K. Takara et al., “Effects of reactive oxygen species on cell proliferation and death in HeLa cells and its MDR1-overexpressing derivative cell line,” Biological and Pharmaceutical Bulletin, vol. 26, no. 2, pp. 278–281, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. R. O'Connor, “The pharmacology of cancer resistance,” Anticancer Research, vol. 27, no. 3 A, pp. 1267–1272, 2007. View at Google Scholar · View at Scopus
  45. L. Roncuzzi, F. Pancotti, and N. Baldini, “Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells,” Oncology Reports, vol. 32, no. 1, pp. 389–394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Seebacher, D. J. Lane, D. R. Richardson et al., “Turning the gun on cancer: utilizing lysosomal P-glycoprotein as a new strategy to overcome multi-drug resistance,” Free Radical Biology & Medicine, vol. 96, no. 1, pp. 432–445, 2016. View at Google Scholar
  47. C. Michiels, E. Minet, D. Mottet, and M. Raes, “Regulation of gene expression by oxygen: NF-κB and HIF-1, two extremes,” Free Radical Biology and Medicine, vol. 33, no. 9, pp. 1231–1242, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. C.-W. Hsu, R. Huang, T. Khuc et al., “Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling,” Oncotarget, vol. 7, no. 7, pp. 8172–8183, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. Z. Al Taleb, A. Petry, T. F. Chi et al., “Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2,” Journal of Molecular Medicine, vol. 94, no. 10, pp. 1153–1166, 2016. View at Publisher · View at Google Scholar
  50. S. M. M. Yahya, A. R. Hamed, M. Emara, M. M. Soltan, G. E. F. Abd-Ellatef, and S. M. Abdelnasser, “Differential effects of c-myc and ABCB1 silencing on reversing drug resistance in HepG2/Dox cells,” Tumor Biology, vol. 37, no. 5, pp. 5925–5932, 2016. View at Publisher · View at Google Scholar · View at Scopus